12.3155.99% ( -0.785 )
Trading: Nov 16, 11:46:50 (EDT)News
Iambic Therapeutics tumbles 9%
Market Movers·Bank of America Names 2 'Strong Buy' Stocks With 60%+ Upside
Tip Ranks·- Bank of America has highlighted Iambic Therapeutics and Supernus as two biotech and pharmaceutical stocks with over 60% upside potential. - Iambic Therapeutics utilizes an AI platform for accelerated drug discovery, with its lead candidate IAM1363 showing promising clinical data for HER2-driven cancers. - Supernus recently completed a merger with Indivior Pharmaceuticals to create an expanded central nervous system leader with enhanced profitability and cost-saving expectations.Iambic Therapeutics surges 8%
Market Movers·Iambic Therapeutics surges 16%
Market Movers·
